RBI retains interest rate, LG Electronics IPO, FPI exit, BCCI response, S&P 500's best month in 15 years

In today's newsletter, we take a look at the RBI's decision to retain interest rate and policy stance, LG Electronics IPO, S&P 500 recorded its best September in 15 years, a hike in commercial LPG prices and more
RBI retains interest rate, LG Electronics IPO, FPI exit, BCCI response, S&P 500's best month in 15 years
RBI Governor Sanjay Malhotra
Profile Image
CNBCTV18·author
Published Oct 01, 2025   |   1:11 AM GMT-04
Share
·
Add us onAdd us on Google

RBI leaves repo rate, stance unchanged; FY26 GDP growth forecast raised


The Monetary Policy Committee (MPC) of the Reserve Bank of India kept its benchmark interest rates unchanged at 5.5% on Wednesday, October 1, marking the second consecutive pause following three consecutive rate cuts worth 100 basis points across February, April and June.


Read More



Crimes against women rise slightly in 2023, UP reports highest cases, says NCRB data


India recorded nearly 4.5 lakh cases of crimes against women in 2023, marking a marginal increase from the previous two years, the National Crime Records Bureau (NCRB) data revealed.


Read More



Commercial LPG cylinder price hiked by ₹15.50 from today


The oil marketing companies have revised the prices of commercial LPG cylinders on Wednesday (October 1). The rate of a 19 kg commercial LPG cylinder has been increased by ₹15.50, effective from today.


Read More



LG Electronics India IPO — Key risk factors for investors to know


LG Electronics India Ltd., the consumer durables and home appliances company, has announced that its three-day initial public offer (IPO) will open for subscription on Tuesday, October 7, and close on Thursday, October 9.


Read More



S&P 500 reports best September in 15 years as investors shrug off shutdown worries


Benchmark indices on Wall Street ended the session higher on Tuesday in what was another choppy trading session to round off a seasonally weak September and the quarter, with gains.


Read More



FPI exits from Indian markets hit all-time high on tariff and earnings fears


Foreign portfolio investors (FPIs) have pulled $17.3 billion from Indian equities so far in 2025, making it the largest annual outflow on record, as concerns over US tariffs and slowing earnings weigh on sentiment.


CNBC-TV18 Access



BCCI raises strong objection over Asia Cup trophy fiasco in ACC AGM but Naqvi defiant


The BCCI on Tuesday (September 30) raised ”strong objection” in the Asian Cricket Council’s AGM over India not being presented the winner’s trophy of the Asia Cup, but the body’s chairman Mohsin Naqvi remained defiant by ”still not agreeing” to it.


Read More



HUDCO sanctions ₹92,710 crore loans, disbursements up 44% in Q2


Housing and Urban Development Corporation Limited (HUDCO) on Tuesday (September 30) announced its business performance for the quarter and half-year ended September 30, 2025. The company said that against total loan sanctions of ₹1,27,952 crore achieved during the financial year 2024-25, it has recorded loan sanctions of ₹92,709.60 crore (provisional, subject to audit) for the half year ended September 30, 2025.


Read More



Tata Group’s market value wipeout nears half its annual revenue


With export-driven companies bearing the brunt of the Trump administration's trade policies, the Tata Group has emerged as the biggest casualty. So far in 2025, India’s largest conglomerate has shed ₹5.4 lakh crore in market capitalisation, with a large portion of the erosion occurring in recent weeks.


CNBC-TV18 Access



GST on hotels slashed, but bills remain the same-here's why


Travellers who thought their hotel bills would be lighter on their pockets after September 22 have come in for a bit of a shock. Despite the recent GST rate reduction on hotel rooms, travellers report little to no decrease in their bills.


Read More



Donald Trump, Pfizer seal the deal to cut U.S. drug prices


U.S. President Donald Trump announced a deal with Pfizer to reduce prescription drug costs in the United States on Tuesday. Under the agreement, all new Pfizer drugs will be launched at the most favoured nation price, which aligns U.S. prices with the lowest paid in comparable countries.


Read More


Share
·
Add us onAdd us on Google
Read about our editorial guidelines and ethics policy